KRAS and EGFR mutations coexisting in lung adenocarcinoma

被引：0
|
作者：
Vitor Sousa
Ana Alarcão
Patricia Couceiro
Maria R Silva
Maria J d’Aguiar
Lia Teixeira
Lina Carvalho
机构：
[1] Instituto de Anatomia Patológica,
[2] Faculdade de Medicina da Universidade de Coimbra,undefined
[3] Centro de Investigação em Meio Ambiente,undefined
[4] Genética e Oncobiologia (CIMAGO),undefined
[5] Centro de Pneumologia,undefined
[6] Faculdade de Medicina da Universidade de Coimbra,undefined
[7] Serviço de Anatomia Patológica dos Hospitais da Universidade de Coimbra,undefined
来源：
BMC Proceedings | / 4卷 / Suppl 2期
关键词：
Adenocarcinoma; Tyrosine Kinase Inhibitor; Lung Adenocarcinoma; KRAS Mutation; Downstream Signalling Pathway;
D O I：
10.1186/1753-6561-4-S2-P57
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations
    Hiramatsu, Miyako
    Ninomiya, Hironori
    Inamura, Kentaro
    Nomura, Kimie
    Takeuchi, Kengo
    Satoh, Yukitoshi
    Okumura, Sakae
    Nakagawa, Ken
    Yamori, Takao
    Matsuura, Masaaki
    Morikawa, Toshiaki
    Ishikawa, Yuichi
    [J]. LUNG CANCER, 2010, 70 (01) : 94 - 102
  • [42] Imaging of synchronous multiple primary lung adenocarcinoma with concomitant EGFR and KRAS mutations: a case report and review of the literature
    Ma, Jing-Wen
    Fu, Yong-Liang
    Miao, Lei
    Li, Meng
    [J]. TRANSLATIONAL CANCER RESEARCH, 2021, 10 (05) : 2509 - 2515
  • [43] CLINICOPATHOLOGICAL AND PROGNOSTIC SIGNIFICANCE OF INTERLEUKIN-8 EXPRESSION AND ITS RELATIONSHIP TO KRAS AND EGFR MUTATIONS IN LUNG ADENOCARCINOMA
    Sunaga, Noriaki
    Tomizawa, Yoshio
    Shimizu, Kimihiro
    Imai, Hisao
    Kaira, Kyoichi
    Takahashi, Gen
    Kakegawa, Seiichi
    Ohtaki, Yoichi
    Nagashima, Toshiteru
    Kasahara, Norimitsu
    Nishioka, Masaki
    Kamide, Yosuke
    Koga, Yasuhiko
    Ono, Akihiro
    Hisada, Takeshi
    Kawashima, Osamu
    Dobashi, Kunio
    Saito, Ryusei
    Yamada, Masanobu
    [J]. RESPIROLOGY, 2013, 18 : 151 - 151
  • [44] Simultaneous KRAS and EGFR mutations: A single laboratory's experience in 1,384 lung adenocarcinoma samples
    Eles, K.
    Toth, E.
    Szoke, J.
    [J]. VIRCHOWS ARCHIV, 2013, 463 (02) : 134 - 134
  • [45] Are all RAS mutations the same? Coexisting KRAS and NRAS mutations in a caecal adenocarcinoma and contiguous tubulovillous adenoma
    Vagaja, N. N.
    Parry, J.
    McCallum, D.
    Thomas, M. A.
    Bentel, J. M.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (08) : 657 - 660
  • [46] Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations
    Letícia Ferro Leal
    Flávia Escremim de Paula
    Pedro De Marchi
    Luciano de Souza Viana
    Gustavo Dix Junqueira Pinto
    Carolina Dias Carlos
    Gustavo Noriz Berardinelli
    José Elias Miziara
    Carlos Maciel da Silva
    Eduardo Caetano Albino Silva
    Rui Pereira
    Marco Antonio de Oliveira
    Cristovam Scapulatempo-Neto
    Rui Manuel Reis
    [J]. Scientific Reports, 9
  • [47] Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations
    Leal, Leticia Ferro
    de Paula, Flavia Escremim
    De Marchi, Pedro
    Viana, Luciano de Souza
    Junqueira Pinto, Gustavo Dix
    Carlos, Carolina Dias
    Berardinelli, Gustavo Noriz
    Miziara, Joseprime Elias
    da Silva, Carlos Maciel
    Albino Silva, Eduardo Caetano
    Pereira, Rui
    de Oliveira, Marco Antonio
    Scapulatempo-Neto, Cristovam
    Reis, Rui Manuel
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [48] Clinicopathological characteristics of lung adenocarcinoma with EGFR compound mutations
    Hayashi, Takuo
    Kohsaka, Shinji
    Takamochi, Kazuya
    Hara, Kieko
    Takahashi, Fumiyuki
    Suehara, Yoshiyuki
    Saito, Tsuyoshi
    Suzuki, Kenji
    Mano, Hiroyuki
    Yao, Takashi
    [J]. MODERN PATHOLOGY, 2019, 32
  • [49] Clinicopathological characteristics of lung adenocarcinoma with compound EGFR mutations
    Hayashi, Takuo
    Kohsaka, Shinji
    Takamochi, Kazuya
    Hara, Kieko
    Kishikawa, Satsuki
    Sano, Kei
    Takahashi, Fumiyuki
    Suehara, Yoshiyuki
    Saito, Tsuyoshi
    Takahashi, Kazuhisa
    Suzuki, Kenji
    Yao, Takashi
    [J]. HUMAN PATHOLOGY, 2020, 103 : 42 - 51
  • [50] EGFR Mutations in Asian Patients with Advanced Lung Adenocarcinoma
    Liam, Chong-Kin
    Pang, Yong-Kek
    Poh, Mau-Ern
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : E70 - E71
12345